LivaNova (LIVN) Total Non-Current Liabilities (2015 - 2026)
LivaNova recorded quarterly Total Non-Current Liabilities of $1.3 billion in Q1 2026, down 8.31% quarter-over-quarter from $1.4 billion in Q4 2025, and down 13.11% year-over-year from $1.4 billion in Q1 2025.
LivaNova's Total Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $1.3 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 13.11% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (down 13.11% YoY), while the FY2025 annual figure was $1.4 billion, up 19.48% from the prior year.
- Total Non-Current Liabilities came in at $1.3 billion for Q1 2026 at LivaNova, down from $1.4 billion in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $1.4 billion in Q1 2025 to a low of $920.2 million in Q2 2022.
- A 5-year average of $1.1 billion and a median of $1.1 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities retreated 26.91% in 2022 and gained 24.37% in 2025, its largest moves.
- LivaNova's Total Non-Current Liabilities stood at $995.6 million in 2022, then grew by 7.58% to $1.1 billion in 2023, then grew by 6.59% to $1.1 billion in 2024, then grew by 19.48% to $1.4 billion in 2025, then retreated by 8.31% to $1.3 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $1.3 billion, $1.4 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | 1.25 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Bn |
| Dec 31, 2025 | 1.36 Bn |
| Sep 30, 2025 | 1.34 Bn |
| Jun 30, 2025 | 1.33 Bn |
| Mar 31, 2025 | 1.44 Bn |
| Dec 31, 2024 | 1.14 Bn |
| Sep 30, 2024 | 1.13 Bn |
| Jun 30, 2024 | 1.11 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.07 Bn |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Mar 31, 2023 | 1.02 Bn |
| Dec 31, 2022 | 995.59 Mn |
| Sep 30, 2022 | 984.07 Mn |
| Jun 30, 2022 | 920.15 Mn |
| Mar 31, 2022 | 1.04 Bn |
| Dec 31, 2021 | 819.48 Mn |
| Sep 30, 2021 | 890.91 Mn |
| Jun 30, 2021 | 1.26 Bn |
| Mar 31, 2021 | 1.16 Bn |
| Dec 31, 2020 | 1.23 Bn |
| Sep 30, 2020 | 1.11 Bn |
| Jun 30, 2020 | 1.10 Bn |
| Mar 31, 2020 | 962.00 Mn |
| Dec 31, 2019 | 913.68 Mn |
| Sep 30, 2019 | 1.00 Bn |
| Jun 30, 2019 | 1.01 Bn |
| Mar 31, 2019 | 965.66 Mn |
| Dec 31, 2018 | 1.02 Bn |
| Sep 30, 2018 | 661.08 Mn |
| Jun 30, 2018 | 774.50 Mn |
| Mar 31, 2018 | 701.92 Mn |
| Dec 31, 2017 | 653.47 Mn |
| Sep 30, 2017 | 614.30 Mn |
| Jun 30, 2017 | 614.50 Mn |
| Mar 31, 2017 | 597.96 Mn |
| Dec 31, 2016 | 600.65 Mn |
| Sep 30, 2016 | 652.90 Mn |
| Jun 30, 2016 | 671.43 Mn |
| Mar 31, 2016 | 760.67 Mn |
| Dec 31, 2015 | 717.53 Mn |
| Oct 18, 2015 | 8.25 Mn |
| Apr 24, 2015 | 7.92 Mn |